Bio2 Technologies is a medical device company organized around development of advanced orthobiomaterials utilizing a proprietary process capable of producing structures that are both strong and porous. The company produces a range of biocompatible materials by applying CLM, a propriety cross-linked microstructure fiber bonding process. Bio2 develops in-growth coatings, highly porous structural materials, and tissue scaffolds for use in musculoskeletal clinical practice. The firm also commercializes implantable devices constructed from these materials for distribution through exclusive marketing partners.
